For Investors

Overview

Since 2005, CoMotion (formerly C4C) has supported the commercialization of more than 100 innovative ideas. Let our dedicated team connect you with UW researchers doing cutting-edge work.

Company Spotlight

ron-myers_244x218.jpg
Nexgenia CEO Ron Myers

Nexgenia's new CEO zeros in on immunotherapy

When Ron Myers left the Institute for Systems Biology to become CEO of UW startup Nexgenia, he shifted the company’s direction to focus on one of the key challenges in commercializing immunotherapy: accurately and quickly sorting out the T cells from a patient’s blood so they can be activated and sent back into the patient’s body to battle cancer cells.

Come to An Event

Help Us Find Talent

We are always looking for exceptional individuals to join our Entrepreneurs In Residence program or to be a mentor. To learn more, give us a call (206.543.3790) or send us an email

Get Involved

To learn more about investor opportunities at UW, please contact:

Chris Igielski,
Associate Director for Early Stage Funding
cti2@uw.edu
206-543-9222